// COMPANY
Thermo Fisher Scientific
// OVERVIEW
Global life sciences company and flagship OpenAI enterprise customer using AI to accelerate FDA drug approvals.
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
mention·All In·JUNE 2, 2026
“Thermo Fisher wants to be able to get patient screening done faster so they get FDA approval faster. That's really important. Like, if you have a form of cancer where you have weeks to live, the difference between a breakthrough in four weeks and two weeks can literally be life or death.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.